North America Molecular Diagnostics Market (2016-2022)

  • ID: 4091217
  • Report
  • Region: America, North America, United States
  • 106 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Grifols
  • Qiagen N.V
  • Roche Diagnostics
  • MORE
Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.

High prevalence of Infectious diseases in USA is growing the demand for molecular diagnostic market. According to the Centers of Diseases Control and Prevention, Hepatics C is the leading cause of death in America. In 2014, deaths associated with Hepatics C were all-time high of 19,659. Currently, around 3.5 million Americans are still living with Hepatic C. Additionally; Tuberculosis is also becoming one of the leading causes of death. According to World Health Organisation (WHO), “tuberculosis, malaria and AIDS have caused over 300 million illnesses and more than 5 million deaths each year worldwide and the most effected region is North America. Hence, it could be expected that high prevelance of diseases could result in growth of molecular devices market in North America.

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.

Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into US, Canada and Mexico.

The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Grifols
  • Qiagen N.V
  • Roche Diagnostics
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Molecular Diagnostics Market, by Product & Services
1.4.2 Europe Molecular Diagnostics Market, by Technology
1.4.3 Europe Molecular Diagnostics Market, by Application
1.4.4 Europe Molecular Diagnostics Market, by End User
1.4.5 Europe Molecular Diagnostics Market, by Country
1.5 Methodology for the research

2. Executive Summary

3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints

4. Europe Molecular Diagnostics Market
4.1 Europe Molecular Diagnostics Market by Product & Services
4.1.1 Europe Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 Europe Molecular Diagnostics Instruments Market by Country
4.1.3 Europe Molecular Diagnostics Software & Services Market by Country

5. Europe Molecular Diagnostics Market by Technology
5.1 Introduction
5.1.1 Europe Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 Europe Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 Europe Hybridization Molecular Diagnostics Market by Country
5.1.4 Europe DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 Europe Microarray Molecular Diagnostics Market by Country
5.1.6 Europe Other Technologies Market by Country

6. Europe Molecular Diagnostics Market by Application
6.1 Introduction
6.1.1 Europe Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 Europe Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 Europe Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 Europe Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 Europe Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 Europe Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 Europe Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 Europe Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 Europe Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 Europe Oncology Molecular Diagnostics Market by Country
6.1.4 Europe Oncology Molecular Diagnostics Market by Type
6.1.4.1 Europe Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 Europe Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 Europe Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 Europe Other Cancers Molecular Diagnostics Market by Country
6.1.5 Europe Blood Screening Molecular Diagnostics Market by Country
6.1.6 Europe Genetic Tests Molecular Diagnostics Market by Country
6.1.7 Europe Microbiology Molecular Diagnostics Market by Country
6.1.8 Europe Other Applications Market by Country

7. Europe Molecular Diagnostics Market by End User
7.1 Introduction
7.1.1 Europe Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 Europe Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 Europe Molecular Diagnostics Market for Other End Users by Country

8. Europe Molecular Diagnostics Market by Country
8.1 Introduction
8.2 Germany Molecular Diagnostics Market
8.2.1 Germany Molecular Diagnostics Market by Product & Services
8.2.2 Germany Molecular Diagnostics Market by Technology
8.2.3 Germany Molecular Diagnostics Market by Application
8.2.3.1 Germany Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 Germany Oncology Molecular Diagnostics Market by Type
8.2.4 Germany Molecular Diagnostics Market by End User
8.3 UK Molecular Diagnostics Market
8.3.1 UK Molecular Diagnostics Market by Product & Services
8.3.2 UK Molecular Diagnostics Market by Technology
8.3.3 UK Molecular Diagnostics Market by Application
8.3.3.1 UK Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 UK Oncology Molecular Diagnostics Market by Type
8.3.4 UK Molecular Diagnostics Market by End User
8.4 France Molecular Diagnostics Market
8.4.1 France Molecular Diagnostics Market by Product & Services
8.4.2 France Molecular Diagnostics Market by Technology
8.4.3 France Molecular Diagnostics Market by Application
8.4.3.1 France Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 France Oncology Molecular Diagnostics Market by Type
8.4.4 France Molecular Diagnostics Market by End User
8.5 Russia Molecular Diagnostics Market
8.5.1 Russia Molecular Diagnostics Market by Product & Services
8.5.2 Russia Molecular Diagnostics Market by Technology
8.5.3 Russia Molecular Diagnostics Market by Application
8.5.3.1 Russia Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 Russia Oncology Molecular Diagnostics Market by Type
8.5.4 Russia Molecular Diagnostics Market by End User
8.6 Spain Molecular Diagnostics Market
8.6.1 Spain Molecular Diagnostics Market by Product & Services
8.6.2 Spain Molecular Diagnostics Market by Technology
8.6.3 Spain Molecular Diagnostics Market by Application
8.6.3.1 Spain Infectious Diseases Molecular Diagnostics Market by Type
8.6.3.2 Spain Oncology Molecular Diagnostics Market by Type
8.6.4 Spain Molecular Diagnostics Market by End User
8.7 Italy Molecular Diagnostics Market
8.7.1 Italy Molecular Diagnostics Market by Product & Services
8.7.2 Italy Molecular Diagnostics Market by Technology
8.7.3 Italy Molecular Diagnostics Market by Application
8.7.3.1 Italy Infectious Diseases Molecular Diagnostics Market by Type
8.7.3.2 Italy Oncology Molecular Diagnostics Market by Type
8.7.4 Italy Molecular Diagnostics Market by End User
8.8 Rest of Europe Molecular Diagnostics Market
8.8.1 Rest of Europe Molecular Diagnostics Market by Product & Services
8.8.2 Rest of Europe Molecular Diagnostics Market by Technology
8.8.3 Rest of Europe Molecular Diagnostics Market by Application
8.8.3.1 Rest of Europe Infectious Diseases Molecular Diagnostics Market by Type
8.8.3.2 Rest of Europe Oncology Molecular Diagnostics Market by Type
8.8.4 Rest of Europe Molecular Diagnostics Market by End User

9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Qiagen N.V
  • Roche Diagnostics
  • Grifols
  • Siemens Healthcare (Siemens AG)
  • Becton Dickinson and Company
  • Danaher Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll